back
  

Profile
Search

Related Medications

Molecule
Salt Composition

Equine Rabies Immunoglobulin 1500IU

hero_image
Equirab 1500IU Injection 5ml
Bharat Serums & Vaccines Ltd.
Vial of 5 ml

506.5

14% OFF

MRP 589

Molecule
Salt Composition

Equine Rabies Immunoglobulin 300IU

hero_image
Abhay RIG 300IU Injection 5ml
Indian Immunologicals Ltd.
Vial of 5 ml
MRP

635

No Substitute
Sorry, Substitute Medicine is Unavailable
Molecule
Salt Composition

Equine Rabies Immunoglobulin 1000IU

hero_image
Zyrig 1000IU Injection
Zydus Cadila
Vial of 5 ml
MRP

405

No Substitute
Sorry, Substitute Medicine is Unavailable
Molecule
Salt Composition

Equine Rabies Immunoglobulin 1000IU

hero_image
Imorab 1000IU Injection 5ml
Sanofi India Ltd.
Vial of 5 ml
MRP

625

No Substitute
Sorry, Substitute Medicine is Unavailable
Molecule
Salt Composition

Equine Rabies Immunoglobulin 1200IU

hero_image
Carig 1200IU Injection
Cadila Healthcare Ltd.
Vial of 1 ml
MRP

350

No Substitute
Sorry, Substitute Medicine is Unavailable

Frequently asked questions

The pain associated with Equine Rabies Immunoglobulin administration varies by individual pain tolerance. The injection is typically given at the bite site, which can be painful. A larger volume may be necessary to effectively treat the wound and alleviate pain.
Rabies is entirely preventable. When used alongside proper wound care and the anti-rabies vaccine (ARV), Equine Rabies Immunoglobulin is highly effective in preventing rabies, even after high-risk exposure.
Equine Rabies Immunoglobulin should be administered intramuscularly. If a large volume is needed (greater than 2 mL for children or 5 mL for adults), it should be divided among different sites. It is important to administer the immunoglobulin and the anti-rabies vaccine at separate injection sites.
Equine Rabies Immunoglobulin is not necessary for patients who have completed a full rabies vaccination series.
Equine Rabies Immunoglobulin is more cost-effective than human rabies immunoglobulin (HRIG), making it more accessible for patients in developing countries like India. However, it carries a risk of severe allergic reactions, including anaphylaxis and serum sickness, which makes some physicians cautious about its use.